More than 10,000 globally sourced SARS-CoV-2 genomes are publicly available, and powerful data sharing and analysis platforms like the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database [13] and Nextstrain [14] enable the collaborative analysis of viral population structure on a global level.